Skip to main content

 Scientific publications

New Perspectives in Treating Acute Myeloid Leukemia: Driving towards a Patient-Tailored Strategy.

Authors : Andreozzi F, Massaro F, Wittnebel S, Spilleboudt C, Lewalle P, Salaroli A
Year : 2022
Journal : Int J Mol Sci
Volume : 23

Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis.

Authors : Martins-Branco D, Nader-Marta G, Tecic Vuger A, Debien V, Ameye L, Brandão M, Punie K, Loizidou A, Willard-Gallo K, Spilleboudt C, Awada A, Piccart M, de Azambuja E
Year : 2022
Journal : J Cancer Res Clin Oncol
Pages : 1-6

Acute Promyelocytic Leukaemia (Apl) In The Elderly Patient.

Authors : Salaroli A, Spilleboudt C, Lewalle P, Wittnebel S
Year : 2021
Journal : Belgian J Hematology
Volume : 12(8)
Pages : 332–7

Donor-Derived Myeloid Heme Oxygenase-1 Controls the Development of Graft-Versus-Host Disease.

Authors : Spilleboudt C, de Wilde V, Lewalle P, Cabanne L, Leclerc M, Beckerich F, Bories D, Cardoso S, Soares MP, Vokaer B, Hougardy JM, Flamand V, Racapé J, Abramowicz M, Maury S, Le Moine A
Year : 2021
Journal : Front Immunol
Volume : 11
Pages : 579151

SARS-CoV-2 infection in hematological patients during allogenic stem cell transplantation: A double case report.

Authors : Van Uytvanck A, Wittnebel S, Meuleman N, Loizidou A, Salengros JC, Spilleboudt C
Year : 2021
Journal : Clin Case Rep
Volume : 9
Pages : e04439

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma.

Authors : Merryman RW, Castagna L, Giordano L, Ho VT, Corradini P, Guidetti A, Casadei B, Bond DA, Jaglowski S, Spinner MA, Arai S, Lowsky R, Shah GL, Perales MA, De Colella JMS, Blaise D, Herrera AF, Shouse G, Spilleboudt C, Ansell SM, Nieto Y, Badar T, Hamadani M, Feldman TA, Dahncke L, Singh AK, McGuirk JP, Nishihori T, Chavez J, Serritella AV, Kline J, Mohty M, Dulery R, Stamatoulas A, Houot R, Manson G, Moles-Moreau MP, Orvain C, Bouabdallah K, Modi D, Ramchandren R, Lekakis L, Beitinjaneh A, Frigault MJ, Chen YB, Lynch RC, Smith SD, Rao U, Byrne M, Romancik JT, Cohen JB, Nathan S, Phillips T, Joyce RM, Rahimian M, Bashey A, Ballard HJ, Svoboda J, Torri V, Sollini M, De Philippis C, Magagnoli M, Santoro A, Armand P, Zinzani PL, Carlo-Stella C
Year : 2021
Journal : Leukemia
Volume : 35
Pages : 2672-2683

Mantle cell lymphoma simulating inflammatory bowel disease.

Authors : Lifrange F, de Wind R, Spilleboudt C, Karfis I, Van Gossum A, Demetter P
Year : 2021
Journal : Acta Gastroenterol Belg
Volume : 84
Pages : 125-127

Factors associated with SARS-CoV-2 infection and outcome in patients with solid tumors or hematological malignancies: a single-center study.

Authors : Goudsmit A, Cubilier E, Meert AP, Aftimos P, Stathopoulos K, Spilleboudt C, Loizidou A
Year : 2021
Journal : Support Care Cancer

Chimeric antigen receptor T-cell lymphoma immunotherapy: the next questions.

Authors : Salaroli A, Spilleboudt C, Bron D, Lewalle P
Year : 2020
Journal : Curr Opin Oncol
Volume : 32
Pages : 434-441

Allogeneic stem cell transplantation for acquired pure red cell aplasia.

Authors : Halkes C, de Wreede LC, Knol C, Simand C, Aljurf M, Tbakhi A, Vazquez L, Bloor A, Wagner-Drouet E, Vural F, Bodova I, Isaksson C, Diaz MÁ, Gruhn B, Snowden J, Arat M, Bazarbachi A, Spilleboudt C, Kulagin A, Marsh JC, Passweg J, Risitano AM, Peffault de Latour R, Dufour C
Year : 2019
Journal : Am J Hematol
Volume : 94
Pages : E294-E296

Long-term follow-up of 2 patients treated with 90Y-rituximab radioimmunotherapy for relapse of nodular lymphocyte-predominant Hodgkin lymphoma.

Authors : Golstein SC, Muylle K, Vercruyssen M, Spilleboudt C, de Wind A, Bron D
Year : 2018
Journal : Eur J Haematol
Volume : 101
Pages : 415-417

Malignant or benign hyperleukocytosis ?

Authors : Spilleboudt C, Thibaut P, Varlet E, Bron D
Year : 2018
Journal : Rev Med Brux
Volume : 39
Pages : 291-295